Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3771501012 | Product containing only siltuximab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3771502017 | Siltuximab only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only siltuximab in parenteral dose form (medicinal product form) | Count of base of active ingredient | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Product containing only siltuximab in parenteral dose form (medicinal product form) | Is a | Product containing only siltuximab (medicinal product) | true | Inferred relationship | Some | ||
| Product containing only siltuximab in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing only siltuximab in parenteral dose form (medicinal product form) | Is a | Siltuximab-containing product in parenteral dose form | true | Inferred relationship | Some | ||
| Product containing only siltuximab in parenteral dose form (medicinal product form) | Has active ingredient | Siltuximab | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Siltuximab 100 mg powder for solution for injection vial | Is a | False | Product containing only siltuximab in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| Siltuximab 400 mg powder for solution for injection vial | Is a | False | Product containing only siltuximab in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | Is a | True | Product containing only siltuximab in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| Siltuximab 100 mg powder for solution for infusion and/or injection vial | Is a | True | Product containing only siltuximab in parenteral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR